New Hodgkin Lymphoma Combo Therapy of Keytruda and AFM13 to Move into Clinical Trial
News
Affimed Therapeutics N.V. , a German clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, reports that it has entered into an immuno-oncology clinical research collaboration with ... Read more